van de Kar N C, Sauerwein R W, Demacker P N, Grau G E, van Hinsbergh V W, Monnens L A
Department of Pediatrics, University Hospital, Nijmegen, The Netherlands.
Nephron. 1995;71(3):309-13. doi: 10.1159/000188737.
The cytokines tumor necrosis factor-alpha (TNF-alpha) and its soluble TNF receptors 55 and 75 (sTNFR55, sTNFR75), interleukin-1 beta (IL-1BETA) and interleukin-6 (IL-6) were measured in plasma from 13 patients with the hemolytic uremic syndrome (HUS) on admission. No significant changes in the plasma levels of TNF-alpha and IL-1beta were detected in the HUS patients as compared to the plasma levels of the control groups. Levels of IL-6 were significantly elevated in the plasma of those HUS patients who had external manifestations, consisting of seizures, loss of consciousness, coma and pancreatic necrosis. Although the exact function of IL-6 in the plasma of HUS patients is still unknown and the group of HUS patients is small, plasma IL-6 is associated with the the severity and outcome of the disease. Plasma levels of sTNR55 and sTNFR75 were significantly elevated in all HUS patients compared to the healthy controls, but they were also elevated in the children with chronic renal failure. This indicates that elevated levels of circulating sTNFR should be carefully interpreted when kidney failure exists.
对13例溶血尿毒综合征(HUS)患者入院时的血浆进行检测,测定其中细胞因子肿瘤坏死因子-α(TNF-α)及其可溶性TNF受体55和75(sTNFR55、sTNFR75)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)的水平。与对照组血浆水平相比,未检测到HUS患者血浆中TNF-α和IL-1β水平有显著变化。在有癫痫发作、意识丧失、昏迷和胰腺坏死等外在表现的HUS患者血浆中,IL-6水平显著升高。虽然IL-6在HUS患者血浆中的确切功能仍不清楚,且HUS患者群体较小,但血浆IL-6与疾病的严重程度和预后相关。与健康对照组相比,所有HUS患者血浆中sTNR55和sTNFR75水平均显著升高,但慢性肾衰竭儿童的这两种受体水平也升高。这表明,当存在肾衰竭时,对循环中sTNFR水平升高的情况应谨慎解读。